Amgen Inc (AMGN)

4,760.00
-84.26(-1.74%)
  • Volume:
    7
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    4,760.00 - 4,760.00

AMGN Overview

Prev. Close
4,844.26
Day's Range
4,760-4,760
Revenue
19.48B
Open
4,760
52 wk Range
4,581.29-5,746.53
EPS
12.54
Volume
7
Market Cap
2.54T
Dividend (Yield)
8.52
(3.22%)
Average Volume (3m)
688
P/E Ratio
20.24
Beta
0.648
1-Year Change
2.67%
Shares Outstanding
533,579,206
Next Earnings Date
-
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc News

Amgen Inc Analysis

Amgen Inc Company Profile

Amgen Inc Company Profile

Employees
24200
  • Type:Equity
  • Market:Mexico
  • ISIN:US0311621009
  • S/N:031162100

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Analyst Price Target

Average268.60 (+5.89% Upside)
High325.00
Low180.00
Price253.65
No. of Analysts21
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellNeutral
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryStrong SellSellStrong SellStrong SellSell